Today, Swiss Goldsmith, committed to becoming a leading professional dermatology company in the world, officially landed on the SIX Swiss Exchange, which will be the initial public offering (IPO) of the exchange in 2024. Goldman Sachs (stock code: "GALD") opened at CHF 61.00 per share, with a market value of CHF 14.5 billion (about 116.4 billion yuan).
The issued share capital of Goldman Sachs Group Co., Ltd. ("Goldman Sachs Group") includes 237897635 registered shares, of which 37233708 newly issued registered shares and 276909 existing registered shares were issued in the initial public offering. Calculated at the issue price of CHF 53.00 per registered share, the allotment amount is about CHF 2 billion (excluding the over allotment right). In addition, as part of the over allotment rights, the shareholders also sold up to 5626592 existing registered shares, which can be registered in Swiss Stock Exchange Exercise the over allotment right within 30 calendar days after the first trading day. This is the largest IPO placement in Switzerland since 2017.
Goldsmith plans to use the proceeds from IPO mainly for debt repayment and refinancing, aiming to strengthen the company's financial position. From March 25, 2024, Goldman Sachs will be included in the Swiss Performance Index (SPI) and its sub indexes.
Dr. Flemming Ø rnskov, CEO of Goldsmith, pointed out that he was proud of the company's successful listing on the Swiss Stock Exchange. He emphasized Goldsmith's determination to further consolidate its market leadership through its innovative injection aesthetics, daily skin care and skin treatment products, He also expressed his gratitude to all employees for their hard work and contributions over the years.
Jos Dijsselhof, CEO of the Swiss Stock Exchange, said, "We welcome the participation of Goldman Sachs, which will strengthen the position of the Exchange as the preferred platform for Europe's leading consumers and healthcare companies." He expressed optimistic expectations for the future of Goldman Sachs as a listed company, and looked forward to the future cooperation between the two sides in the capital market.
